3H9-13049-41616
4 vaccinations
5 coded responses
40 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 270 / NC
- Registered
- 2021-01-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
8FT-17075-58182
Child or adolescent in my care · Male · 2022-06-25
Timeline
-
2020-12-23
Dose 1 — Pfizer-BioNTech
-
2021-01-13
Registered in v-safe
-
2021-01-13
Dose 2 — Pfizer-BioNTech
- 2021-01-13
-
2021-01-14
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Swollen lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-14
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-21
- 2021-01-27
- 2021-02-03
- 2021-02-10
- 2021-02-17
- 2021-02-24
-
2021-04-14
Survey response — 3 months, dose 2MedDRA: Plantar fasciitis — Feeling: GoodFree text: Plantar fasciitis left footMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-14
-
2021-09-29
Dose 3 — Pfizer-BioNTech
- 2021-09-29
-
2021-09-30
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-10-01
- 2021-10-02
- 2021-10-03
- 2021-10-04
- 2021-10-05
- 2021-10-06
- 2021-10-13
- 2021-10-20
-
2021-10-27
Survey response — day 28, dose 3MedDRA: Abdominal pain, Nausea — Feeling: Good · Be unable to do your normal daily activitiesFree text: Intermittent abdominal pain and nauseaMedDRA releases: 2024-11 · check-in free text available
-
2021-11-06
Survey response — day 35, dose 3MedDRA: Pregnancy — Feeling: GoodFree text: Just found out 4 weeks pregnant.MedDRA releases: 2024-11 · check-in free text available
- 2021-11-10
-
2021-12-29
Survey response — 3 months, dose 3MedDRA: Pregnancy — Feeling: GoodFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
- 2022-03-30
-
2022-09-21
Dose 4 — Pfizer-BioNTech
- 2022-09-26
- 2022-09-27
- 2022-09-28
- 2022-10-05
- 2022-10-12
- 2022-10-19
- 2022-10-26
- 2022-11-02
- 2022-12-21
- 2023-03-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech | |
| 2 | 2021-01-13 | Pfizer-BioNTech | |
| 3 | 2021-09-29 | Pfizer-BioNTech | No |
| 4 | 2022-09-21 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-14 | priority 2/3 |
Free text
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Swollen lymph nodes
Release 7 — 3 months, dose 2
Symptoms: Plantar fasciitis left foot
Release 10 — day 28, dose 3
Symptoms: Intermittent abdominal pain and nausea
Release 10 — day 35, dose 3
Symptoms: Just found out 4 weeks pregnant.
Release 10 — 3 months, dose 3
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal pain | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Plantar fasciitis | ✓ | ✓ | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release